Advisor Group Inc. Grows Holdings in Thermo Fisher Scientific Inc (TMO)

Advisor Group Inc. grew its holdings in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 10.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,762 shares of the medical research company’s stock after buying an additional 1,214 shares during the quarter. Advisor Group Inc.’s holdings in Thermo Fisher Scientific were worth $2,416,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Covington Capital Management raised its holdings in shares of Thermo Fisher Scientific by 0.9% during the second quarter. Covington Capital Management now owns 2,144 shares of the medical research company’s stock worth $374,000 after purchasing an additional 20 shares during the period. Investment Centers of America Inc. raised its holdings in shares of Thermo Fisher Scientific by 1.6% during the second quarter. Investment Centers of America Inc. now owns 1,317 shares of the medical research company’s stock worth $230,000 after purchasing an additional 21 shares during the period. Fort Washington Investment Advisors Inc. OH raised its holdings in shares of Thermo Fisher Scientific by 0.4% during the second quarter. Fort Washington Investment Advisors Inc. OH now owns 6,250 shares of the medical research company’s stock worth $1,090,000 after purchasing an additional 23 shares during the period. Azimuth Capital Management LLC raised its holdings in shares of Thermo Fisher Scientific by 0.8% during the first quarter. Azimuth Capital Management LLC now owns 3,210 shares of the medical research company’s stock worth $493,000 after purchasing an additional 25 shares during the period. Finally, Bienville Capital Management LLC raised its holdings in shares of Thermo Fisher Scientific by 1.6% during the second quarter. Bienville Capital Management LLC now owns 1,687 shares of the medical research company’s stock worth $295,000 after purchasing an additional 27 shares during the period. Institutional investors own 86.16% of the company’s stock.

A number of analysts have weighed in on TMO shares. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 target price on the stock in a report on Thursday, September 7th. Morgan Stanley restated an “overweight” rating and set a $220.00 price target on shares of Thermo Fisher Scientific in a research report on Wednesday, September 6th. Cowen restated an “outperform” rating and set a $220.00 price target (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Sunday, September 10th. Deutsche Bank set a $226.00 price target on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Thursday, October 26th. Finally, Leerink Swann restated a “buy” rating on shares of Thermo Fisher Scientific in a research report on Monday, October 30th. One equities research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $205.21.

Thermo Fisher Scientific Inc (TMO) traded down $0.56 during trading hours on Monday, hitting $192.20. 1,335,400 shares of the stock traded hands, compared to its average volume of 1,545,250. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.81 and a current ratio of 1.26. Thermo Fisher Scientific Inc has a one year low of $139.32 and a one year high of $201.20. The company has a market cap of $77,071.31, a price-to-earnings ratio of 21.12, a price-to-earnings-growth ratio of 1.76 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, beating analysts’ consensus estimates of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The company had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same period in the prior year, the firm earned $2.03 earnings per share. The business’s quarterly revenue was up 13.9% on a year-over-year basis. equities analysts forecast that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.31%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 10.19%.

In other news, CEO Marc N. Casper sold 50,000 shares of the stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total value of $9,419,500.00. Following the completion of the sale, the chief executive officer now directly owns 252,577 shares of the company’s stock, valued at $47,582,981.03. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Peter E. Hornstra sold 3,894 shares of the stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $185.18, for a total transaction of $721,090.92. Following the completion of the sale, the vice president now directly owns 19,751 shares of the company’s stock, valued at $3,657,490.18. The disclosure for this sale can be found here. 0.49% of the stock is currently owned by corporate insiders.

WARNING: “Advisor Group Inc. Grows Holdings in Thermo Fisher Scientific Inc (TMO)” was first reported by Community Financial News and is the property of of Community Financial News. If you are reading this article on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this article can be viewed at https://www.com-unik.info/2017/12/04/advisor-group-inc-grows-holdings-in-thermo-fisher-scientific-inc-tmo.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit